Martijn S Visser

2PUBLICATIONS
0CO-AUTHORS
Reproductive medicine not elsewhere classifiedClinical neuropsychology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 16, 2020
Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trial.

Martijn S Visser, Sankha Amarakoon, Tom Missotten

|Mar 20, 2020
A very short version of the Visual Function Questionnaire (VFQ-3oo7) for use as a routinely applied Patient-Reported Outcome Measure.

Martijn S Visser, Reinier Timman, Karlijn J Nijmeijer

Pageof 1

Frequent Collaborators